VeMico has a total of 6 patents globally, out of which no patent have been granted. Of these 6 patents, more than 16% patents are active. United Kingdom is where VeMico has filed the maximum number of patents. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of VeMico.
VeMico was founded in 2018. The company develops a series of natural, food-grade nutraceuticals derived from the microbiome, designed to promote healthy aging by addressing inflammation.
Do read about some of the most popular patents of VeMico which have been covered by us in this article and also you can find VeMico patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over VeMico patent portfolio.
How many patents does VeMico have?
VeMico has a total of 6 patents globally. These patents belong to 5 unique patent families. Out of 6 patents, 1 patent are active.
How Many Patents did VeMico File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | VeMico Applications Filed | VeMico Patents Granted |
| 2022 | 2 | – |
| 2021 | 1 | – |
| 2020 | 2 | – |
| 2018 | 1 | – |
How many VeMico patents are Alive/Dead?
Worldwide Patents
How Many Patents did VeMico File in Different Countries?
The company VeMico filled all there patents in USA.
Where are Research Centers of VeMico Patents Located?
The Research Centers of VeMico Patents is the United States of America.
List of VeMico patents
| VeMico Patents | Title |
| WO2023131774A1 | Compositions And Methods For Immunomodulation Via Control Of Intestinal Microbiome |
| GB202200069D0 | Compositions And Methods For Immunomodulation Via Control Of Intestinal Microbiome |
| GB202101789D0 | Use Of Bifidobacterium Breve, Extract Or Polysac-Charide Thereform For Antiaging, Antiinflammation And Hormonal Regulation |
| GB202001534D0 | Use Of Bifidobacterium Breve, Extract Or Polysac-Charide Thereform For Antigaing, Antiinflammation And Hormonal Regualtion |
| GB202000717D0 | Vmk Therapeutics |
| GB201819713D0 | Method For Directing The Immune System Function Using De Novo Designed Glycans |
What Technologies are Covered by VeMico?
The chart below distributes patents filed by VeMico